Trade Bristol Myers ^BMY

Bristol Myers Squibb Company $BMY Shares Purchased by Geneos Wealth Management Inc. - Markets Daily

Is Bristol-Myers Squibb (BMY) Reasonable After Its 32% Run?

Aware Super Pty Ltd as trustee of Aware Super Purchases New Shares in Bristol Myers Squibb Company $BMY - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Investors Purchase High Volume of Call Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax

Investors Buy Large Volume of Bristol Myers Squibb Call Options (NYSE:BMY)

Illinois Municipal Retirement Fund Sells 87,210 Shares of Bristol Myers Squibb Company $BMY

Bank of New York Mellon Corp Sells 1,194,538 Shares of Bristol Myers Squibb Company $BMY

Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Morningstar

Diversify Wealth Management LLC Acquires 21,775 Shares of Bristol Myers Squibb Company $BMY

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Valuespectrum.com

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar

Bristol Myers Squibb (BMY) Following FDA Acceptance Has An Undervalued Case

Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.

Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia

Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis

Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight

Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma | Morningstar

Global consortium releases AI toolbox to unlock new Alzheimer's treatments

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Kestra Advisory Services LLC Increases Holdings in Bristol Myers Squibb Company $BMY

Castleview Partners LLC Sells 11,554 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

KLCM Advisors Inc. Sells 19,755 Shares of Bristol Myers Squibb Company $BMY

Candriam S.C.A. Cuts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Conning Inc.

Did FTSE Russell's Reclassification and Dividend Streak Just Shift Bristol-Myers Squibb's (BMY) Investment Narrative?

Bristol Myers Squibb (NYSE:BMY) Price Target Cut to $66.00 by Analysts at Bank of America

Bank of America Issues Pessimistic Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Stock Observer

Summit Securities Group LLC Sells 82,290 Shares of Bristol Myers Squibb Company $BMY

U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals - NaturalNews.com

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

The PRECISE European initiative for cancer-vulnerability mapping and prediction

Associations of plasma MMP-9 and MPO with functional outcome in moderate to severe acute ischemic stroke

Connective Tissue Disease Associated with Interstitial Lung Disease Market Report, Details Drug Class Breakdown Across Corticosteroids, Antifibrotics, Immunosuppressants, and Biologics

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

Bristol-Myers Squibb's Q2 2026 Earnings: What to Expect

R Squared Ltd Sells 17,443 Shares of Bristol Myers Squibb Company $BMY - Zolmax

Burney Co. Trims Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Sumitomo Mitsui Trust Group Inc. - Daily Political

Merck & Company (MRK) Gets a Buy from RBC Capital

Bristol Myers Squibb names Singapore as new Pan Asia Hub

Swedbank AB Has $179.63 Million Stake in Bristol Myers Squibb Company $BMY - Zolmax

Walser Wealth Management Company A Ltd Liability Co Invests $592,000 in Bristol Myers Squibb Company $BMY - Stock Observer

Swedbank AB Sells 17,734 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning

PFG Investments LLC Sells 10,347 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

PFG Investments LLC Has $2.82 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Hudson Edge Investment Partners Inc. Has $8.42 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab

Keybank National Association OH Raises Holdings in Bristol Myers Squibb Company $BMY

Strs Ohio Sells 32,917 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Keybank National Association OH - Stock Observer

Bristol Myers Squibb Company $BMY Shares Acquired by Counterpoint Mutual Funds LLC - Stock Observer

Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights

BMY's Shift Into Russell Value Defensive Indexes Might Change The Case For Investing In Bristol-Myers Squibb (BMY)

Bristol Myers Squibb Company $BMY Shares Sold by Pzena Investment Management LLC

Bristol Myers Squibb Company $BMY Stock Position Lowered by iA Global Asset Management Inc.

Bristol Myers Squibb Company $BMY Shares Sold by iA Global Asset Management Inc.

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

Bristol-Myers Squibb (BMY) Joins Arcus Biosciences to Test a New Two-Drug Kidney Cancer Combination

Bristol Myers Squibb (BMY) Joins Defensive Value Indexes, Is It Still 8% Undervalued?

Casdatifan 在肾癌中表现出与 HIF-2α 生物学相关的持久疗效

USS Investment Management Ltd Buys 20,383 Shares of Bristol Myers Squibb Company $BMY

Venture Capital & Startup Funding Roundup, June 30, 2026

Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?

Pictet Asset Management Holding SA Sells 73,242 Shares of Bristol Myers Squibb Company $BMY

There's A Lot To Like About Bristol-Myers Squibb's (NYSE:BMY) Upcoming US$0.63 Dividend - Simply Wall St News

Janney Montgomery Scott LLC Has $46.72 Million Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily

Janney Montgomery Scott LLC Purchases 49,310 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis

Fort Washington Investment Advisors Inc. OH Reduces Holdings in Bristol Myers Squibb Company $BMY

Union Bancaire Privee UBP SA Purchases 63,563 Shares of Bristol Myers Squibb Company $BMY

Sterling Capital Management LLC Has $10.33 Million Position in Bristol Myers Squibb Company $BMY - Stock Observer

Ritholtz Wealth Management Boosts Stock Position in Bristol Myers Squibb Company $BMY

OP Asset Management Ltd Takes Position in Bristol Myers Squibb Company $BMY

The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy

Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

Bristol Myers Follows Novartis, Sues Arkansas Over Pharmacy Law

Faithward Advisors LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study

Bristol Myers Squibb (NYSE:BMY) Shares Unloaded Rep. Mike Kelly - Stock Observer

Bristol-Myers Squibb Company (BMY) and SystImmune Announce Results from Analyses of Iza-bren Studies

Bristol Myers Squibb (BMY) Stock Could Be 13% Undervalued As Pipeline Plans Take Shape

Brookstone Capital Management Acquires 35,588 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Holdings Lifted by Corient Private Wealth LLC

Innovent-Pfizer deal makes joint development, commercialization pillar in biotech global push - Chinadaily.com.cn

Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

Keytruda Market Trends, Analysis and Forecast - Express Press Release Distribution

KRAS Inhibitors Market is Poised for Robust Growth by 2036 Driven by Expanding KRAS-Targeted Therapies and Rising Adoption Across Multiple Oncology Indications | DelveInsight

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk